Evidence map›Paper›PMID 40840523›Full record

ArticleEndocrinology, diabetes & metabolism case reports2025

A rare form of endogenous hypoglycemia uncovered after corticosteroid treatment.

Adina Simona Dragomir, Georgiana Cristina Taujan, Mihai Vlad Dragan, Luciana Gavrizi-Zafiu, Daniela Doina Chiriac, Dana Larisa Geru, Diana Loreta Paun

Abstract read
In one paragraph

Article in Endocrinology, diabetes & metabolism case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Adina Simona DragomirC I Parhon National Institute of Endocrinology, Bucharest, Romania.ORCID https://orcid.org/0009-0005-8364-0066
Georgiana Cristina TaujanClinique d'Endocrinologie, CHU Brugmann, Bruxelles, Belgium.
Mihai Vlad DraganC I Parhon National Institute of Endocrinology, Bucharest, Romania.
Luciana Gavrizi-ZafiuC I Parhon National Institute of Endocrinology, Bucharest, Romania.
Daniela Doina ChiriacC I Parhon National Institute of Endocrinology, Bucharest, Romania.
Dana Larisa GeruC I Parhon National Institute of Endocrinology, Bucharest, Romania.
Diana Loreta PaunThe University Emergency Hospital of Bucharest, Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Summary: We present the case of a 52-year-old Caucasian woman with insulin autoimmune syndrome (IAS) uncovered after corticosteroid treatment for lumbar pain due to disc herniation. We confirmed hypoglycemic episodes 4-5 h after food ingestion, associated with extremely high levels of insulin and the presence of anti-insulin antibodies, establishing the diagnosis of IAS. The most probable cause of the disease was glucocorticoid medication, considering she had no other autoimmune or hematologic disease associated. As the hypoglycemic episodes were mild, the patient received dietary recommendations (small, frequent, low-carbohydrate meals), and 3 months later, she had no more clinical episodes of hypoglycemia, with improved blood insulin level. Learning points: IAS is a very rare form of hypoglycemia in the Caucasian population, which is why critical thinking and active search are needed. Moreover, drug-induced cases of IAS in the Caucasian population are exceptional, with only one report of glucocorticoid medication as a trigger in the literature. Recognizing IAS is very important in order to avoid unnecessary investigations and choose the right treatment.

Indexed as

anti-insulin antibodiesautoimmune hypoglycemiaglucocorticoid medication

Identifiers

PMID40840523
PMCPMC12365950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.